1. Mathe G, Halle-Pannenko O, Bourut C: Effectiveness of murine leukemia chemotherapy according to the immune state.Cancer Immun Immunother
2, 39 (1977).
2. Lubet R A, Carlson D E: Therapy of murine plasmacytoma MOPC 104E: role of the immune response.J natn Cancer Inst
61, 897 (1978).
3. Hengst J C D, Mokyr M B, Dray S: Importance of timing of cyclophosphamide therapy of MOPC-315 tumor bearing mice.Cancer Res
40, 2135 (1980).
4. Mokyr M B, Dray S: Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low rather than a high dose of cyclophosphamide.Cancer Res
43, 3112 (1983).
5. Hilgard P, Pohl J, Stekar J, Voegeli R: Oxazaphosphorines as biological response modifiers: experimental and clinical perspectives.Cancer Treat Rep
12, 155 (1985).